Late-onset myasthenia gravis follow-up of 113 patients diagnosed after age 60

Annals of the New York Academy of Sciences

Volumn 841, Issue , 1998, Pages 777-780

  Slesak, Gerhard ^a   Melms, Arthur ^a   Gerneth, Friederike ^b   Sommer, Norbert ^a   Weissert, Robert ^a   Dichgans, Johannes ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Institute of Medical Information Processing   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; STEROID;

ADULT; AGED; CATARACT; CONFERENCE PAPER; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYASTHENIA GRAVIS; NERVE STIMULATION; OSTEOPOROSIS; QUESTIONNAIRE; THYMECTOMY; THYMOMA;

EID: 0031903149     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb11017.x     Document Type: Article

References (6)

1. LANSKA, D. J. 1990. Indications for thymectomy in myasthenia gravis. Neurology 40: 1828-1829.
2. SOMMER, N. et al. 1997. Ocular myasthenia gravis: response to long-term immunosuppressive treatment. J. Neurol. Neurosurg. Psychiatry 62: 156-162.
3. BEVER, C. T. et al. 1983. Prognosis of ocular myasthenia gravis. Ann. Neurol. 14:516-519.
4. OOSTERHUIS, H. J. G. H. 1989. The natural course of myasthenia gravis: a long-term followup study. J. Neurol. Neurosurg. Psychiatry 52: 1121-1127.
5. EVOLI, A. et al. 1992. Long-term results of corticosteroid therapy in patients with myasthenia gravis. Eur. Neurol. 32: 37-43.
6. HOHLFELD, R. et al. 1985. Myasthenia gravis: reactivation of clinical disease and of autoimmune factors after discontinuation of long-term azathioprine. Ann. Neurol. 17: 238-242.